The latest generation of the Ekso Bionics platform, the EksoNR previously received clearance for stroke and spinal cord rehabilitation in 2016, then acquired brain injury (ABI) in 2020
EVO is the latest industrial exoskeleton from Ekso Bionics, designed to be lighter and more flexible than previous wearable robots. It was created with customer feedback.
As global demand for robotic rehabilitation and assistive technologies grows, developers must be aware of emerging applications. Transparency Market Research offers examples of areas of interest.
Ekso Bionics, the Richmond, Calif.-based developer of medical and industrial exoskeletons, today unveiled EksoNR, the next-generation version of its EksoGT. The EksoNR is designed to help patients who are recovering from stroke or other conditions learn to walk again with a more natural gait. The EksoNR includes new features to help physical therapists and patients…
Many of the most visible demonstrations of exoskeletons have been for assisting people with disabilities. However, limitations of weight, power, and cost have resulted in slow rates of adoption. In the meantime, the technology continues to advance, with industrial exoskeletons providing application experience. While the majority of today’s $130 million wearable robotics market is for…
